New drug application (NDA) NDA content
New
drug application (NDA)
Critical
component for drug approval process which required to submit to USFDA before
drug commercialization.
The
data gathered during the animal studies and human clinical trials of IND become
part of the NDA.
Goal
The
NDA provide enough information to permit FDA reviewer to reach safety, efficacy
and quality for pharmaceutical production.
NDA
content
1. Index
2. Labeling
3. Summary
4. Chemistry
section
5. Nonclinical
pharmacology and toxicology section
6. Human
pharmacokinetics and bioavailability section
7. Clinical
microbiology section
8. Clinical
data section
9. Safety update report
10. Statistical section
11. Case report tabulations
12. Case report forms
13. Patent information on any patent
14. Patent certification
15. Establishment description
16. Debarment certification
17. Field copy certification
18. User fee cover sheet
19. Financial information
Comments
Post a Comment